1. Home
  2. Analysis
  3. Maxalt-mlt
  4. Mitoxantrone

Maxalt-mlt and Mitoxantrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt-mlt (rizatriptan benzoate) and Mitoxantrone (mitoxantrone hydrochloride). Common drug interactions include abdominal pain among females.

The phase IV clinical study analyzes what interactions people have when they take Maxalt-mlt and Mitoxantrone. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt-mlt?

Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.

What is Mitoxantrone?

Mitoxantrone has active ingredients of mitoxantrone hydrochloride. eHealthMe is studying from 8,125 Mitoxantrone users. Check the latest studies of Mitoxantrone.

On Jul, 13, 2026

24 people who take Maxalt-mlt and Mitoxantrone together, and have interactions are studied.

Maxalt-mlt and Mitoxantrone drug interactions.

What are the common drug interactions of Maxalt-Mlt and Mitoxantrone, by gender? *:

female:

  1. Abdominal pain
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Fistula (an abnormal connection or passageway between two)
  4. Haematochezia (passage of stools containing blood)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Impaired healing
  7. Injury
  8. Lung neoplasm malignant (cancer tumour of lung)
  9. Nausea (feeling of having an urge to vomit)
  10. Neoplasm (tumour)

male:

n/a

What are the common drug interactions of Maxalt-Mlt and Mitoxantrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Fistula (an abnormal connection or passageway between two)
  4. Haematochezia (passage of stools containing blood)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Impaired healing
  7. Injury
  8. Lung neoplasm malignant (cancer tumour of lung)
  9. Nausea (feeling of having an urge to vomit)
  10. Neoplasm (tumour)

60+:

n/a

What are the existing conditions these people have? *

  1. Ovarian Cancer (cancer of ovary): 24 people, 100.00%
  2. Neoplasm Malignant (cancer tumour): 24 people, 100.00%
  3. Hot Flush (sudden feelings of heat): 24 people, 100.00%
  4. Discomfort: 24 people, 100.00%
  5. Breast Cancer Metastatic: 24 people, 100.00%
  6. Breast Cancer: 24 people, 100.00%
  7. Granulocyte Count Decreased: 23 people, 95.83%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt-mlt and Mitoxantrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxalt-mlt and Mitoxantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mitoxantrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxalt-mlt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mitoxantrone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate and mitoxantrone hydrochloride (the active ingredients of Maxalt-mlt and Mitoxantrone, respectively), and Maxalt-mlt and Mitoxantrone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.